Related content

Reply to limitations in the imputation strategy to handle missing nativity data in the Surveillance, Epidemiology, and End Results program

By Zhou Renke   Montealegre Jane R.   Amirian E. Susan   Scheurer Michael E.  

Cancer, Vol. 120, Iss. 20, 2014-10 ,pp. : 3262-3263

Blackwell Publishing

Access to resources Recommend Favorite

Uncovering nativity disparities in cancer patterns: Multiple imputation strategy to handle missing nativity data in the Surveillance, Epidemiology, and End Results data file

By Montealegre Jane R.   Zhou Renke   Amirian E. Susan   Scheurer Michael E.  

Cancer, Vol. 120, Iss. 8, 2014-04 ,pp. : 1203-1211

Blackwell Publishing

Access to resources Recommend Favorite

Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results–Medicare data, 1998-2007

By Haynes Alex B.   You Y. Nancy   Hu Chung-Yuan   Eng Cathy   Kopetz E. Scott   Rodriguez-Bigas Miguel A.   Skibber John M.   Cantor Scott B.   Chang George J.  

Cancer, Vol. 120, Iss. 8, 2014-04 ,pp. : 1162-1170

Blackwell Publishing

Access to resources Recommend Favorite

Missing Data Imputation in Quality-of-Life Assessment: Imputation for WHOQOL-BREF

By Ting Hsiang Lin  

PharmacoEconomics, Vol. 24, Iss. 9, 2006-01 ,pp. : 917-925

Adis International

Access to resources Recommend Favorite

Does adjuvant radiotherapy benefit patients with diffuse-type gastric cancer? Results from the Surveillance, Epidemiology, and End Results database

By  

Cancer, Vol. 120, Iss. 22, 2014-11 ,pp. : 3562-3568

Blackwell Publishing

Access to resources Recommend Favorite